Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells

References

• Lee WC, Kopetz S, Wistuba II, Zhang J. Metastasis of cancer: when and how? Ann Oncol. 2017;28(9):2045–13. doi:10.1093/annonc/mdx327.
   PubMed Web of Science ®Google Scholar
• Ganesh K, Massagué J. Targeting metastatic cancer. Nat Med. 2021;27(1):34–44. doi:10.1038/s41591-020-01195-4.
   PubMed Web of Science ®Google Scholar
• Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153(3):865–873. doi:10.1016/S0002-9440(10)65628-3.
   PubMed Web of Science ®Google Scholar
• Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ, Muschel RJ. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 2001;61:333–338.
   PubMed Web of Science ®Google Scholar
• Hu Z, Curtis C. Looking backward in time to define the chronology of metastasis. Nat Commun. 2020;11(1):3213. doi:10.1038/s41467-020-16995-y.
   PubMed Web of Science ®Google Scholar
• Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. Published online January 28, 2021;39(13):1485–1505. doi:10.1200/JCO.20.03399.
   PubMed Web of Science ®Google Scholar
• Asselain B, Barlow W, Bartlett J, Bergh J, Bergsten-Nordström E, Bliss J, Boccardo F, Boddington C, Bogaerts J, Bonadonna G, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39. doi:10.1016/S1470-2045(17)30777-5.
   PubMed Web of Science ®Google Scholar
• D’Alterio C, Scala S, Sozzi G, Roz L, Bertolini G. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. Semin Cancer Biol. 2020;60:351–361. doi:10.1016/j.semcancer.2019.08.019.
   PubMed Web of Science ®Google Scholar
• Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Sharma VP, Xue EA, Cheng E, D’Alfonso TM, et al. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci Transl Med. 2017;9(397). doi:10.1126/scitranslmed.aan0026.
   PubMed Web of Science ®Google Scholar
• Wills CA, Liu X, Chen L, Zhao Y, Dower CM, Sundstrom J, Wang HG. Chemotherapy-induced upregulation of small extracellular vesicle-associated PTX3 accelerates breast cancer metastasis. Cancer Res. 2021;81(2):452–463. doi:10.1158/0008-5472.CAN-20-1976.
   PubMed Web of Science ®Google Scholar
• Keklikoglou I, Cianciaruso C, Güç E, Squadrito ML, Spring LM, Tazzyman S, Lambein L, Poissonnier A, Ferraro GB, Baer C, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol. 2019;21(2):190–202. doi:10.1038/s41556-018-0256-3.
   PubMed Web of Science ®Google Scholar
• Haj-Shomaly J, Vorontsova A, Barenholz-Cohen T, Levi-Galibov O, Devarasetty M, Timaner M, Raviv Z, Cooper TJ, Soker S, Hasson P, et al. T cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy. Cancer Res. 2022;82(2):278–291. doi:10.1158/0008-5472.CAN-21-1012.
   PubMed Web of Science ®Google Scholar
• Middleton JD, Sivakumar S, Hai T. Chemotherapy-induced changes in the lung microenvironment: the role of MMP-2 in facilitating intravascular arrest of breast cancer cells. Int J Mol Sci. 2021;22(19):10280. doi:10.3390/ijms221910280.
   PubMed Web of Science ®Google Scholar
• Karagiannis GS, Condeelis JS, Oktay MH. Chemotherapy-induced metastasis: molecular mechanisms, clinical manifestations, therapeutic interventions. Cancer Res. 2019;79(18):4567–4576. doi:10.1158/0008-5472.CAN-19-1147.
   PubMed Web of Science ®Google Scholar
• Ba Y, Shi Y, Jiang W, Feng J, Cheng Y, Xiao L, Zhang Q, Qiu W, Xu B, Xu R, et al. Current management of chemotherapy-induced neutropenia in adults: key points and new challenges. Cancer Biol Med. 2020;17(4):896–909. doi:10.20892/j.issn.2095-3941.2020.0069.
   PubMed Web of Science ®Google Scholar
• Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia. Cancer. 2004;100(2):228–237. doi:10.1002/cncr.11882.
   PubMed Web of Science ®Google Scholar
• Wculek SK, Malanchi I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature. 2015;528(7582):413–417. doi:10.1038/nature16140.
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau C-S, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345–348. doi:10.1038/nature14282.
   PubMed Web of Science ®Google Scholar
• Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, et al. Neutrophils suppress intraluminal NK cell–mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov. 2016;6(6):630–649. doi:10.1158/2159-8290.CD-15-1157.
   PubMed Web of Science ®Google Scholar
• Faget J, Groeneveld S, Boivin G, Sankar M, Zangger N, Garcia M, Guex N, Zlobec I, Steiner L, Piersigilli A, et al. Neutrophils and snail orchestrate the establishment of a pro-tumor microenvironment in lung cancer. Cell Rep. 2017;21(11):3190–3204. doi:10.1016/j.celrep.2017.11.052.
   PubMed Web of Science ®Google Scholar
• Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, Scheidmann MC, Donato C, Scherrer R, Singer J, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. Published online February 6, 2019;566(7745):553–557. doi:10.1038/s41586-019-0915-y.
   PubMed Web of Science ®Google Scholar
• Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011;20(3):300–314. doi:10.1016/j.ccr.2011.08.012.
   PubMed Web of Science ®Google Scholar
• Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AAR, Wauters E, Walmsley S, Prenen H, Granot Z, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015;522(7556):349–353. doi:10.1038/nature14407.
   PubMed Web of Science ®Google Scholar
• Massara M, Bonavita O, Savino B, Caronni N, Mollica Poeta V, Sironi M, Setten E, Recordati C, Crisafulli L, Ficara F, et al. ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity. Nat Commun. 2018;9(1):676. doi:10.1038/s41467-018-03080-8.
   PubMedGoogle Scholar
• Cui C, Chakraborty K, Tang XA, Zhou G, Schoenfelt KQ, Becker KM, Hoffman A, Chang Y-F, Blank A, Reardon CA, et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021;184(12):3163–3177.e21. doi:10.1016/j.cell.2021.04.016.
   PubMed Web of Science ®Google Scholar
• Giavazzi R, Scholar E, Hart IR. Isolation and preliminary characterization of an adriamycin-resistant murine fibrosarcoma cell line. Cancer Res. 1983;43:2216–2222.
   PubMed Web of Science ®Google Scholar
• Rovida A, Castiglioni V, Decio A, Scarlato V, Scanziani E, Giavazzi R, Cesca M. Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice. Mol Cancer Ther. 2013;12(10):2237–2247. doi:10.1158/1535-7163.MCT-13-0244.
   PubMed Web of Science ®Google Scholar
• Man S, Zhang Y, Gao W, Yan L, Ma C. Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma. Clin Exp Metastasis. 2008;25(8):855–864. doi:10.1007/s10585-008-9201-3.
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM, et al. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res. 2008;68(2):516–520. doi:10.1158/0008-5472.CAN-07-3063.
   PubMed Web of Science ®Google Scholar
• Hattori K, Shimizu K, Takahashi M, Tamura M, Oheda M, Ohsawa N, Ono M. Quantitative in vivo assay of human granulocyte colony-stimulating factor using cyclophosphamide-induced neutropenic mice. Blood. 1990;75(6):1228–1233. doi:10.1182/blood.V75.6.1228.1228.
   PubMed Web of Science ®Google Scholar
• Lord BI, Woolford LB, Molineux G. Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF). Clin Cancer Res Off J Am Assoc Cancer Res. 2001;7:2085–2090.
   PubMed Web of Science ®Google Scholar
• Matsuzaki G, Li XY, Ohyama Y, Nomoto K. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during g-csf treatment of cyclophosphamide-treated mice. Int J Immunopharmacol. 1996;18(6):363–369. doi:10.1016/S0192-0561(96)00039-2.
   PubMed Web of Science ®Google Scholar
• Boivin G, Faget J, Ancey PB, Gkasti A, Mussard J, Engblom C, Pfirschke C, Contat C, Pascual J, Vazquez J, et al. Durable and controlled depletion of neutrophils in mice. Nat Commun. 2020;11(1):2762. doi:10.1038/s41467-020-16596-9.
   PubMed Web of Science ®Google Scholar
• Said R, Abdel-Rehim M, Sadeghi B, Al-Hashemi S, Hassan Z, Hassan M. Cyclophosphamide pharmacokinetics in mice: a comparison between retro orbital sampling versus serial tail vein bleeding. TOPHARMJ. 2007 [cited March 22, 2021].;1(1):30–35. https://benthamopen.com/ABSTRACT/TOPHARMJ-1-30.
   Google Scholar
• Schurig JE, Schlein A, Florczyk AP, Farwell AR, Bradner WT. Animal models for evaluating the myelosuppressive effects of cancer chemotherapeutic agents. Exp Hematol. 1985;13:101–105.
   PubMed Web of Science ®Google Scholar
• Keating GM. Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization. Drugs. 2011;71(6):679–707. doi:10.2165/11206870-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Opasawatchai A, Amornsupawat P, Jiravejchakul N, Chan-In W, Spoerk NJ, Manopwisedjaroen K, Singhasivanon P, Yingtaweesak T, Suraamornkul S, Mongkolsapaya J, et al. Neutrophil Activation and Early Features of NET Formation are Associated with Dengue Virus Infection in Human. Front Immunol. 2019 [cited July 6, 2022];9. doi:10.3389/fimmu.2018.03007.
   PubMed Web of Science ®Google Scholar
• López-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RSK. Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene. 2013;32(14):1752–1760. doi:10.1038/onc.2012.201.
   PubMed Web of Science ®Google Scholar
• Karagiannis GS, Condeelis JS, Oktay MH. Chemotherapy-induced metastasis: mechanisms and translational opportunities. Clin Exp Metastasis. 2018;35(4):269–284. doi:10.1007/s10585-017-9870-x.
   PubMed Web of Science ®Google Scholar
• Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, Vesga O. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect Dis. 2006;6(1):55. doi:10.1186/1471-2334-6-55.
   PubMedGoogle Scholar
• Misaki M, Ueyama Y, Tsukamoto G, Matsumura T. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice. Br J Cancer. 1998;77(6):884–889. doi:10.1038/bjc.1998.146.
   PubMed Web of Science ®Google Scholar
• Russo M, Nastasi C. Targeting the tumor microenvironment: a close up of tumor-associated macrophages and neutrophils. Front Oncol. 2022 [cited July 4, 2022];12. doi:10.3389/fonc.2022.871513.
   Web of Science ®Google Scholar
• Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20(9):485–503. doi:10.1038/s41568-020-0281-y.
   PubMed Web of Science ®Google Scholar
• Spicer JD, McDonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P, Ferri LE. Neutrophils promote liver metastasis via Mac-1–mediated interactions with circulating tumor cells. Cancer Res. 2012;72(16):3919–3927. doi:10.1158/0008-5472.CAN-11-2393.
   PubMed Web of Science ®Google Scholar
• Ponzetta A, Carriero R, Carnevale S, Barbagallo M, Molgora M, Perucchini C, Magrini E, Gianni F, Kunderfranco P, Polentarutti N, et al. Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors. Cell. 2019;178(2):346–360.e24. doi:10.1016/j.cell.2019.05.047.
   PubMed Web of Science ®Google Scholar
• De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457–474. doi:10.1038/nrc.2017.51.
   PubMed Web of Science ®Google Scholar
• Mehta HM, Malandra M, Corey SJ. G-CSF and GM-CSF in neutropenia. J Immunol. 2015;195(4):1341–1349. doi:10.4049/jimmunol.1500861.
   PubMed Web of Science ®Google Scholar
• Lalami Y, Klastersky J. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data. Crit Rev Oncol Hematol. 2017;120:163–179. doi:10.1016/j.critrevonc.2017.11.005.
   PubMed Web of Science ®Google Scholar